Article Versions Notes

Gorenjak M, Jezernik G, Krušič M, Skok P, Potočnik U. Identification of Novel Loci Involved in Adalimumab Response in Crohn’s Disease Patients Using Integration of Genome Profiling and Isoform-Level Immune-Cell Deconvoluted Transcriptome Profiling of Colon Tissue. Pharmaceutics. 2022; 14(9):1893. https://doi.org/10.3390/pharmaceutics14091893

Gorenjak, Mario, Gregor Jezernik, Martina Krušič, Pavel Skok, and Uroš Potočnik. 2022. "Identification of Novel Loci Involved in Adalimumab Response in Crohn’s Disease Patients Using Integration of Genome Profiling and Isoform-Level Immune-Cell Deconvoluted Transcriptome Profiling of Colon Tissue" Pharmaceutics 14, no. 9: 1893. https://doi.org/10.3390/pharmaceutics14091893

Gorenjak, M., Jezernik, G., Krušič, M., Skok, P., & Potočnik, U. (2022). Identification of Novel Loci Involved in Adalimumab Response in Crohn’s Disease Patients Using Integration of Genome Profiling and Isoform-Level Immune-Cell Deconvoluted Transcriptome Profiling of Colon Tissue. Pharmaceutics, 14(9), 1893. https://doi.org/10.3390/pharmaceutics14091893